ASX-Listed Biotech Firm Latest to Adopt a Bitcoin Strategy to Stay Afloat

ASX-listed Opyl Limited, an Australian AI-biotech company grappling with financial stress, announced Thursday in Melbourne that it’s adopting a Bitcoin treasury strategy, joining a growing number of public firms experimenting with the alpha crypto as a lifeline.

Opyl acquired approximately two Bitcoin, valued at roughly $214,500 (AU$330,000), through the DigitalX Bitcoin ETF listed on the ASX. Opyl shares surged more than 47% on the day, according to Yahoo Finance data, as investors reacted to the news. The stock, however, remains down over 68% from its level five years ago.

While that amount is tiny compared to other companies employing the same strategy, Opyl said the move strengthens its “treasury diversification” and reflects its commitment to “aligning shareholder value creation.”

The acquisition is backed by a non-dilutive finance facility extended by non-executive director Antanas “Tony G” Guoga, who also chairs blockchain firm SOL Strategies. Capped at $1.3 million (AU$2 million), the loan carries a 6.5% interest rate and is secured against the company’s Bitcoin holdings.

The Melbourne-based company’s bid to stabilize its financial position comes as it ended the March quarter with just $64,000 (US$41,700) in cash and a funding runway of less than one month.

To meet performance conditions, it allowed 5 million options to lapse, according to an ASX filing. Its quarterly receipts totalled just $2,000 (US$1,300), while operating outflows hit $262,000 (US$170,000). A $1.5 million (US$978,400) licensing deal remains pending as it seeks fresh capital to sustain operations.

Decrypt reached out to Opyl for comment on its financials and Bitcoin strategy, including whether it plans to increase its holdings over time.

Above water with Bitcoin

There is “a measurable global increase in public companies adopting Bitcoin treasuries as a defensive response to financial distress and market volatility,” Mike Eli, founder of Sydney-based crypto derivatives analytics platform Coinperps, told Decrypt.

For instance, daily net inflows for Bitcoin ETFs have logged up to $500 million since April, a metric which “signals robust retail and institutional demand amid uncertainty,” Eli said, citing data from his platform.

Companies following this trend are “capitalizing on the speculative premium” demonstrated by early adopters such as Strategy and Metaplanet, Eli said.

Opyl’s base case for adopting a Bitcoin treasury strategy follows patterns from other distressed companies that sought a safety net through their Bitcoin plays.

Michael Saylor’s Strategy, considered mainly for pioneering the trend, endured years of stagnant growth and declining relevance in enterprise software before gaining recognition.

Semler Scientific, too, was grappling with declining revenues and faced legal troubles before aggressively adopting the digital asset.

GameStop, suffering from poor retail sales and market pressures, similarly tuned in to the trend, although CEO Ryan Cohen has stated that they’re “not following anyone else’s strategy.”

However, Eli warns the strategy “carries risks,” given competition and potential downturns could “trigger forced liquidations and instability.”

Offering caution on the broader factors, Eli claimed fundamentals suggest this Bitcoin strategy could be “a short-term speculative signal rather than a sustainable turnaround tool.”

While Opyl believes its move to be a “disciplined, forward-looking capital allocation framework,” the immediate reality remains: Bitcoin may be its last opportunity to stay afloat.

Still, Guoga urged investors to “take the time to fully understand” crypto. As governments and institutions continue to endorse Bitcoin and other cryptos, these digital assets have been “emerging as a validated and forward-looking asset class,” Guoga said.

Edited by Sebastian Sinclair